Effective Pharmacovigilance Driven By Infrastructure Integration, Cross-Functional Collaboration And Technological Advancement
Heather Stein, MD, MPH, Vice President, Drug Safety and Pharmacovigilance, Boston Biomedical, Inc., and
Partnerships in Action: Advancing Healthcare through Collaborative Science in Emerging Markets
Salman Rizvi, MD, MBA, Anurita Majumdar, MD, Kelly H. Zou, PhD, PStat®, FASA, and Amrit Ray, MD, MBA, Research, Development and Medical, Upjohn Division, Pfizer Inc.
Neuromodulation in Clinical Practice
Hesham Abboud, MD, PhD, Director of the Multiple Sclerosis and Neuroimmunology Program and staff neurologist at the Parkinson’s and Movement Disorder Center at University Hospitals of Cleveland, Case Western Reserve University School of Medicine
Applying AI Technologies in Clinical Trials: Highlighting the Case of Adverse Events in Pharmacovigilance Processes
Nan Shao, PhD, Corporate Vice President, Global Head of Analytics Strategy, Parexel
